Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)

Launched by XIAOQIN LUO · Jan 18, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Nutrition and Cancer Outcomes in Shaanxi Chemoradiotherapy," is looking at how a patient’s nutrition affects their treatment for cancer. Specifically, it aims to see if what you eat can influence how well the treatments like chemotherapy and radiotherapy work and whether they cause more or fewer side effects. The study is currently recruiting participants, and anyone aged 18 and older with a diagnosed cancer who is about to start these treatments may be eligible to join.

Participants should be in good mental health, able to communicate clearly, and willing to attend follow-up visits. However, those with certain conditions, like AIDS or severe mental disorders, or who are pregnant, cannot take part. If you join the study, you will help researchers understand the important role of nutrition in cancer care, which could lead to better treatment outcomes for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 years and above
• • Pathologically diagnosed with malignant tumors
• • Scheduled to undergo radiotherapy and/or chemotherapy
• • Clear consciousness, no communication barriers
• • Willing to undergo follow-up, not in a near-death condition
• Exclusion Criteria:
• • Patients without a pathological diagnosis of malignant tumors
• • Patients with AIDS
• • Patients with mental or cognitive disorders
• • Patients who have undergone organ transplantation
• • Patients with a life expectancy less than 12 months
• • Pregnant women
• • Patients currently participating in other clinical intervention studies